Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Meldex International's Enterprise Value is $0.12 Mil.
Meldex International's EBIT for the trailing twelve months (TTM) ended in Dec. 2007 was $-0.24 Mil. Therefore, Meldex International's EV-to-EBIT ratio for today is -0.50.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Meldex International's Enterprise Value is $0.12 Mil.
Meldex International's EBITDA for the trailing twelve months (TTM) ended in Dec. 2007 was $0.29 Mil. Therefore, Meldex International's EV-to-EBITDA ratio for today is 0.42.
Meldex International Enterprise Value Historical Data
The historical data trend for Meldex International's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Meldex International's Enterprise Value
For the Drug Manufacturers - Specialty & Generic subindustry, Meldex International's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meldex International's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Meldex International's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Meldex International's Enterprise Value falls into.
Meldex International Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Meldex International's Enterprise Value for the fiscal year that ended in Dec. 2007 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meldex International (OTCPK:MLGGY) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Meldex International's current Enterprise Value is $0.12 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Meldex International's EBIT for the trailing twelve months (TTM) ended in Dec. 2007 was $-0.24 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Meldex International's current Enterprise Value is $0.12 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Meldex International's EBITDA for the trailing twelve months (TTM) ended in Dec. 2007 was $0.29 Mil.
Meldex International's current Enterprise Value is $0.12 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Meldex International's Revenue for the trailing twelve months (TTM) ended in Dec. 2007 was $54.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meldex International Enterprise Value Related Terms
Thank you for viewing the detailed overview of Meldex International's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Meldex International PLC is engaged in the sale and marketing of pharmaceutical and other healthcare products. The Company also developments and manufactures cellulose polymer based enabling drug delivery systems and products for the over-the-counter healthcare and pharmaceutical markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MLGGY has been successfully added to your